Codexis, Inc. (CDXS) Awarded U.S. Patent for Biofuels Enzyme
Tweet
Share
E-mailGet Alerts CDXS Hot Sheet
Join SI Premium – FREE
Codexis, Inc. (Nasdaq: CDXS) has been awarded a key patent from the U.S. Patent and Trademark Office covering an important component of the company’s proprietary enzymatic technology that can be used for production of cellulosic biofuels.
Codexis specifically received U.S. Patent No. 8,143,050, “Recombinant Beta-Glucosidase Variants for Production of Soluble Sugars from Cellulosic Biomass”.
Codexis specifically received U.S. Patent No. 8,143,050, “Recombinant Beta-Glucosidase Variants for Production of Soluble Sugars from Cellulosic Biomass”.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Benchmark Reiterates Hold Rating on Codexis, Inc. (CDXS) Amid Transition to New Products/Services
- Real and RE/MAX Holdings receive court approval for merger
- Codexis, Inc. (CDXS) PT Lowered to $8 at Piper Sandler
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
